PI Financial has Initiated Coverage MedReleaf Corp (TSX: LEAF)
Investment Pitch | Season 1
Analyst Jason Zandberg gives the company a buy recommendation along with a speculative risk rating and a 12-month target of $14.50, a premium of 82% to the $7.95 price on June 28th, the day the report was issued.